VM26

DRUG4 trials

Sponsors

Johann Wolfgang Goethe University Hospital, Goethe University

Conditions

Adult Acute Lymphocytic Leukemia

Phase 4

Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia

CompletedNCT00199095

Goethe UniversityAdult Acute Lymphocytic Leukemia

Start: 1997-02-28End: 2003-06-30Target: 40Updated: 2023-03-20

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93)

CompletedNCT00199069

Goethe UniversityAdult Acute Lymphocytic Leukemia

Start: 1993-04-30End: 2001-05-31Target: 720Updated: 2023-03-17

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99)

CompletedNCT00199056

Goethe UniversityAdult Acute Lymphocytic Leukemia

Start: 1999-10-31End: 2005-12-31Target: 225Updated: 2023-03-20

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

CompletedNCT00199004

Johann Wolfgang Goethe University HospitalAdult Acute Lymphocytic Leukemia

Start: 2004-04-30End: 2009-03-31Target: 60Updated: 2010-08-23

Related Papers

Adults with Philadelphia chromosome–like acute lymphoblastic leukemia frequently have <i>IGH-CRLF2</i> and <i>JAK2</i> mutations, persistence of minimal residual disease and poor prognosis

Haematologica2016-08-25161 citations

Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies.

2012-03-22349 citations